The Upcoming Antifungal Drugs in Clinical Development for the Treatment of Invasive Candidiasis

Introduction Invasive candidiasis (IC) continues to be a major cause of morbidity and mortality among hospitalised patients, particularly those admitted to intensive care units and individuals with compromised immune systems.…

Continue ReadingThe Upcoming Antifungal Drugs in Clinical Development for the Treatment of Invasive Candidiasis

New Antibiotics for Treating Infections Caused by Multidrug-Resistant Bacteria

Introduction Antibiotic-resistant bacteria are a growing global threat, causing longer hospital stays, higher costs, and increased mortality. The rise of multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) bacteria—such as…

Continue ReadingNew Antibiotics for Treating Infections Caused by Multidrug-Resistant Bacteria

Oral care medications for the prevention and treatment of ventilator-associated pneumonia in intensive care unit

Introduction Ventilator-associated pneumonia (VAP) is a common and serious infection in ICU patients who undergo invasive mechanical ventilation for more than 48 hours. It is caused by various microorganisms, including…

Continue ReadingOral care medications for the prevention and treatment of ventilator-associated pneumonia in intensive care unit

New β-Lactam/β-Lactamase Inhibitor Combination Antibiotics

Introduction The rise of antimicrobial resistance, especially among Gram-negative bacteria, has led to the development of new β-lactam/β-lactamase inhibitor (BL/BLI) combinations. Recently approved agents—cefepime/enmetazobactam, aztreonam/avibactam, and sulbactam/durlobactam—target resistant pathogens like…

Continue ReadingNew β-Lactam/β-Lactamase Inhibitor Combination Antibiotics

Acinetobacter baumannii Complex Infections: New Treatment Options in the Antibiotic Pipeline

Introduction (Article introduction authored by INCA Editorial Team) Acinetobacter baumannii complex (ABC), particularly its carbapenem-resistant strains (CRAB), presents a significant challenge due to its high resistance to antibiotics and its…

Continue ReadingAcinetobacter baumannii Complex Infections: New Treatment Options in the Antibiotic Pipeline